These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 11511755)
21. Natural killer T cells in families of patients with systemic lupus erythematosus: their possible role in regulation of IGG production. Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR Arthritis Rheum; 2007 Jan; 56(1):303-10. PubMed ID: 17195234 [TBL] [Abstract][Full Text] [Related]
22. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry. Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277 [TBL] [Abstract][Full Text] [Related]
23. Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients. Higgs BW; Zhu W; Richman L; Fiorentino DF; Greenberg SA; Jallal B; Yao Y Int J Rheum Dis; 2012 Feb; 15(1):25-35. PubMed ID: 22324944 [TBL] [Abstract][Full Text] [Related]
24. Lymphokine production in rheumatoid arthritis and systemic lupus erythematosus. McKenna RM; Wilkins JA; Warrington RJ J Rheumatol; 1988 Nov; 15(11):1639-42. PubMed ID: 3148712 [TBL] [Abstract][Full Text] [Related]
25. Interferon production of vitro by leucocytes from patients with systemic lupus erythematosus and rheumatoid arthritis. Neighbour PA; Grayzel AI Clin Exp Immunol; 1981 Sep; 45(3):576-82. PubMed ID: 6175456 [TBL] [Abstract][Full Text] [Related]
26. Association of reduced CD4 T cell responses specific to varicella zoster virus with high incidence of herpes zoster in patients with systemic lupus erythematosus. Park HB; Kim KC; Park JH; Kang TY; Lee HS; Kim TH; Jun JB; Bae SC; Yoo DH; Craft J; Jung S J Rheumatol; 2004 Nov; 31(11):2151-5. PubMed ID: 15517626 [TBL] [Abstract][Full Text] [Related]
27. Alterations in T-lymphocyte sub-set profiles and cytokine secretion by PBMC of systemic lupus erythematosus patients upon in vitro exposure to organochlorine pesticides. Dar SA; Das S; Ramachandran VG; Bhattacharya SN; Mustafa MD; Banerjee BD; Verma P J Immunotoxicol; 2012; 9(1):85-95. PubMed ID: 22214240 [TBL] [Abstract][Full Text] [Related]
28. Roles of 1,25(OH)2D3 and Vitamin D Receptor in the Pathogenesis of Rheumatoid Arthritis and Systemic Lupus Erythematosus by Regulating the Activation of CD4+ T Cells and the PKCδ/ERK Signaling Pathway. He XJ; Ding Y; Xiang W; Dang XQ Cell Physiol Biochem; 2016; 40(3-4):743-756. PubMed ID: 27915349 [TBL] [Abstract][Full Text] [Related]
30. Mucosal-associated invariant T cell deficiency in systemic lupus erythematosus. Cho YN; Kee SJ; Kim TJ; Jin HM; Kim MJ; Jung HJ; Park KJ; Lee SJ; Lee SS; Kwon YS; Kee HJ; Kim N; Park YW J Immunol; 2014 Oct; 193(8):3891-901. PubMed ID: 25225673 [TBL] [Abstract][Full Text] [Related]
31. Relations between surface expression of the interleukin-2 receptor and release of the soluble form of the receptor in cultured mononuclear cells from patients with rheumatoid arthritis or systemic lupus erythematosus. Itoh M; Goto Y; Ohta Y; Goto Y; Ohashi H Clin Rheumatol; 1998; 17(1):26-30. PubMed ID: 9586675 [TBL] [Abstract][Full Text] [Related]
32. Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Viallard JF; Pellegrin JL; Ranchin V; Schaeverbeke T; Dehais J; Longy-Boursier M; Ragnaud JM; Leng B; Moreau JF Clin Exp Immunol; 1999 Jan; 115(1):189-95. PubMed ID: 9933441 [TBL] [Abstract][Full Text] [Related]
33. Differential expression of natural killer activating and inhibitory receptors in patients with newly diagnosed systemic lupus erythematosus. Ye Z; Ma N; Zhao L; Jiang ZY; Jiang YF Int J Rheum Dis; 2016 Jun; 19(6):613-21. PubMed ID: 24617980 [TBL] [Abstract][Full Text] [Related]
34. Serum cortisol reduction and abnormal prolactin and CD4+/CD8+ T-cell response as a result of controlled exercise in patients with rheumatoid arthritis and systemic lupus erythematosus despite unaltered muscle energetics. Pool AJ; Whipp BJ; Skasick AJ; Alavi A; Bland JM; Axford JS Rheumatology (Oxford); 2004 Jan; 43(1):43-8. PubMed ID: 12867581 [TBL] [Abstract][Full Text] [Related]
35. Phenotypic and functional analysis of natural killer cells in systemic lupus erythematosus patients. Chiang BL; Chen YC; Wang CR; Lin YL; Chou CC; Hsieh KH Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(5):357-63. PubMed ID: 8607362 [TBL] [Abstract][Full Text] [Related]
36. Diminished IL-17A levels may protect filarial-infected individuals from development of rheumatoid arthritis and systemic lupus erythematosus. Panda AK; Das BK Lupus; 2017 Apr; 26(4):348-354. PubMed ID: 27488471 [TBL] [Abstract][Full Text] [Related]
37. Lymphocyte reactivity to mitogens in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma. Horwitz DA; Garrett MA Clin Exp Immunol; 1977 Jan; 27(1):92-9. PubMed ID: 300308 [TBL] [Abstract][Full Text] [Related]
38. Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus. Miyasaka N; Nakamura T; Russell IJ; Talal N Clin Immunol Immunopathol; 1984 Apr; 31(1):109-17. PubMed ID: 6421522 [TBL] [Abstract][Full Text] [Related]
39. Serum interleukin-2 receptor in systemic lupus erythematosus and rheumatoid arthritis. Lee GL; Chen MY; Chuang CY; Chen CY Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Feb; 21(1):16-22. PubMed ID: 3264781 [TBL] [Abstract][Full Text] [Related]
40. Soluble interleukin-6 receptor in plasma and in lymphocyte culture supernatants of healthy individuals and patients with systemic lupus erythematosus and rheumatoid arthritis. Polgár A; Brózik M; Tóth S; Holub M; Hegyi K; Kádár A; Hodinka L; Falus A Med Sci Monit; 2000; 6(1):13-8. PubMed ID: 11208277 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]